BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37808686)

  • 21. Familial dysautonomia.
    González-Duarte A; Cotrina-Vidal M; Kaufmann H; Norcliffe-Kaufmann L
    Clin Auton Res; 2023 Jun; 33(3):269-280. PubMed ID: 37204536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial Dysautonomia (FD) Human Embryonic Stem Cell Derived PNS Neurons Reveal that Synaptic Vesicular and Neuronal Transport Genes Are Directly or Indirectly Affected by IKBKAP Downregulation.
    Lefler S; Cohen MA; Kantor G; Cheishvili D; Even A; Birger A; Turetsky T; Gil Y; Even-Ram S; Aizenman E; Bashir N; Maayan C; Razin A; Reubinoff BE; Weil M
    PLoS One; 2015; 10(10):e0138807. PubMed ID: 26437462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dimerization of elongator protein 1 is essential for Elongator complex assembly.
    Xu H; Lin Z; Li F; Diao W; Dong C; Zhou H; Xie X; Wang Z; Shen Y; Long J
    Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10697-702. PubMed ID: 26261306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IKAP/Elp1 involvement in cytoskeleton regulation and implication for familial dysautonomia.
    Cheishvili D; Maayan C; Cohen-Kupiec R; Lefler S; Weil M; Ast G; Razin A
    Hum Mol Genet; 2011 Apr; 20(8):1585-94. PubMed ID: 21273291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rescue of a familial dysautonomia mouse model by AAV9-Exon-specific U1 snRNA.
    Romano G; Riccardi F; Bussani E; Vodret S; Licastro D; Ragone I; Ronzitti G; Morini E; Slaugenhaupt SA; Pagani F
    Am J Hum Genet; 2022 Aug; 109(8):1534-1548. PubMed ID: 35905737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genipin Crosslinks the Extracellular Matrix to Rescue Developmental and Degenerative Defects, and Accelerates Regeneration of Peripheral Neurons.
    Saito-Diaz K; Dietrich P; Wu HF; Sun X; Patel AJ; Wzientek CG; Prudden AR; Boons GJ; Chen S; Studer L; Xu B; Dragatsis I; Zeltner N
    bioRxiv; 2023 Mar; ():. PubMed ID: 36993570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbiome dysbiosis drives metabolic dysfunction in Familial dysautonomia.
    Cheney AM; Costello SM; Pinkham NV; Waldum A; Broadaway SC; Cotrina-Vidal M; Mergy M; Tripet B; Kominsky DJ; Grifka-Walk HM; Kaufmann H; Norcliffe-Kaufmann L; Peach JT; Bothner B; Lefcort F; Copié V; Walk ST
    Nat Commun; 2023 Jan; 14(1):218. PubMed ID: 36639365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a Screening Platform to Identify Small Molecules That Modify ELP1 Pre-mRNA Splicing in Familial Dysautonomia.
    Salani M; Urbina F; Brenner A; Morini E; Shetty R; Gallagher CS; Law EA; Sunshine S; Finneran DJ; Johnson G; Minor L; Slaugenhaupt SA
    SLAS Discov; 2019 Jan; 24(1):57-67. PubMed ID: 30085848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Comprehensive NMR Analysis of Serum and Fecal Metabolites in Familial Dysautonomia Patients Reveals Significant Metabolic Perturbations.
    Costello SM; Cheney AM; Waldum A; Tripet B; Cotrina-Vidal M; Kaufmann H; Norcliffe-Kaufmann L; Lefcort F; Copié V
    Metabolites; 2023 Mar; 13(3):. PubMed ID: 36984872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IKAP/Elp1 is required in vivo for neurogenesis and neuronal survival, but not for neural crest migration.
    Hunnicutt BJ; Chaverra M; George L; Lefcort F
    PLoS One; 2012; 7(2):e32050. PubMed ID: 22384137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial dysautonomia (FD) patients have reduced levels of the modified wobble nucleoside mcm(5)s(2)U in tRNA.
    Karlsborn T; Tükenmez H; Chen C; Byström AS
    Biochem Biophys Res Commun; 2014 Nov; 454(3):441-5. PubMed ID: 25450681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elongator promotes neuritogenesis
    Shilian M; Even A; Gast H; Nguyen L; Weil M
    Front Cell Dev Biol; 2022; 10():1015125. PubMed ID: 36393857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA screening identifies a link between NOVA1 expression and a low level of IKAP in familial dysautonomia.
    Hervé M; Ibrahim EC
    Dis Model Mech; 2016 Aug; 9(8):899-909. PubMed ID: 27483351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of
    Ueki Y; Ramirez G; Salcedo E; Stabio ME; Lefcort F
    eNeuro; 2016; 3(5):. PubMed ID: 27699209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induced pluripotent stem cell (iPSC) lines from two individuals carrying a homozygous (BGUi007-A) and a heterozygous (BGUi006-A) mutation in ELP1 for in vitro modeling of familial dysautonomia.
    Dor L; Rabinski T; Zlotnik D; Shilian M; Weil M; Vatine GD
    Stem Cell Res; 2021 Aug; 55():102495. PubMed ID: 34419746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel ELP1 mutation impairs the function of the Elongator complex and causes a severe neurodevelopmental phenotype.
    Kojic M; Abbassi NEH; Lin TY; Jones A; Wakeling EL; Clement E; Nakou V; Singleton M; Dobosz D; Kaliakatsos M; Glatt S; Wainwright BJ
    J Hum Genet; 2023 Jul; 68(7):445-453. PubMed ID: 36864284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IKBKAP mRNA in peripheral blood leukocytes: a molecular marker of gene expression and splicing in familial dysautonomia.
    Gold-von Simson G; Leyne M; Mull J; Rolnitzky LM; Goldberg JD; Berlin D; Axelrod FB; Slaugenhaupt SA
    Pediatr Res; 2008 Feb; 63(2):186-90. PubMed ID: 18091349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RBM24 promotes U1 snRNP recognition of the mutated 5' splice site in the
    Ohe K; Yoshida M; Nakano-Kobayashi A; Hosokawa M; Sako Y; Sakuma M; Okuno Y; Usui T; Ninomiya K; Nojima T; Kataoka N; Hagiwara M
    RNA; 2017 Sep; 23(9):1393-1403. PubMed ID: 28592461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olfactory stem cells, a new cellular model for studying molecular mechanisms underlying familial dysautonomia.
    Boone N; Loriod B; Bergon A; Sbai O; Formisano-Tréziny C; Gabert J; Khrestchatisky M; Nguyen C; Féron F; Axelrod FB; Ibrahim EC
    PLoS One; 2010 Dec; 5(12):e15590. PubMed ID: 21187979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia.
    Cuajungco MP; Leyne M; Mull J; Gill SP; Lu W; Zagzag D; Axelrod FB; Maayan C; Gusella JF; Slaugenhaupt SA
    Am J Hum Genet; 2003 Mar; 72(3):749-58. PubMed ID: 12577200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.